A Study Comparing Corticosteroids Alone Versus Corticosteroids and Extracorporal Photopheresis (ECP) as First-line Treatment of Standard II Acute Graft-versus-host Disease

NCT03605940 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Acute-graft-versus-host Disease

Interventions

COMBINATION_PRODUCT: Methoxsalen + ECP device
DRUG: Corticosteroids

Sponsor

Central Hospital, Nancy, France